What Has Been the Progress and Growth of the Endocrine Peptide Test Market in Recent Years?
The endocrine peptide test market has seen considerable growth due to a variety of factors.
• The endocrine peptide test market has seen strong growth. It will grow from $9.11 billion in 2024 to $9.97 billion in 2025, at a CAGR of 9.5%.
This growth is attributed to increasing government spending, the rise in diabetes prevalence, decreased immunity levels, higher risks of chronic diseases, and rising government initiatives.
How Does the Forecast Look for the Endocrine Peptide Test Market?
The endocrine peptide test market is expected to maintain its strong growth trajectory in upcoming years.
• The endocrine peptide test market is set to see notable growth, reaching $14.22 billion by 2029 with a CAGR of 9.3%.
Growth drivers include rising demand for these tests, expanding research activities, the increasing prevalence of lifestyle diseases, an aging population, and the growing rates of diabetes. Trends include advancements in testing methods, improvements in product technology, increased R&D to develop novel testing solutions, more product approvals, and a shift toward preventive healthcare.
What Are The Leading Drivers Of Growth In The Endocrine Peptide Test Market?
The rise in diabetes prevalence is expected to propel the growth of the endocrine peptide test market going forward. Diabetes is a condition that leads to high blood sugar levels, and its prevalence is increasing due to unhealthy diets, sedentary lifestyles, genetic factors, and aging. Endocrine peptide tests, such as hemoglobin A1c, fasting plasma glucose, and C-peptide tests, are used to diagnose and monitor diabetes. For example, in June 2024, the National Health Service reported a significant rise in diabetes diagnoses among individuals under 40, from 173,166 in 2022 to 216,440 in 2023. This increase is driving the growth of the endocrine peptide test market.
How Are The Segments Defined Within The Global Endocrine Peptide Test Market?
The endocrine peptide test market covered in this report is segmented –
1) By Test-Type: Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types
2) By Technology: Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies
3) By End-User: Clinics, Healthcare Centers, Hospitals, Commercial Laboratories
Subsegments:
1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
2) By Progesterone: Immunoassay Tests, Chemiluminescence Assays, ELISA Tests
3) By Luteinizing Hormone (LH): Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)
4) By Thyroid Prolactin: Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)
5) By Oestradiol: Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA)
7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA)
8) Other Test-Types: Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH)
Pre-Book The Endocrine Peptide Test Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Endocrine Peptide Test Market?
Companies in the endocrine peptide test market are enhancing accuracy, sensitivity, and speed in testing systems for endocrine peptides. For example, in July 2023, Siemens Healthineers, a Germany-based healthcare company, launched the Atellica CI Analyzer. This system improves testing capabilities for endocrine peptide assays, helping labs quickly and consistently analyze hormone levels and endocrine function, with high throughput and flexibility.
Who Are the Key Players In The Endocrine Peptide Test Market?
Major companies operating in the endocrine peptide test market are:
• Siemens AG
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Becton Dickinson and Company
• Laboratory Corporation of America Holdings (LabCorp)
• Quest Diagnostics Incorporated
• Agilent Technologies Inc.
• Illumina Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Sciex
• Bio-Techne Corporation
• Invitae Corporation
• ARUP Laboratories
• Genova Diagnostics
• Boston Heart Diagnostics Corporation
• Immunodiagnostic Systems Ltd.
• Mayo Clinic Laboratories
What Is The Most Dominant Region In The Endocrine Peptide Test Market?
North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
